Monthly Archives: November 2021

Also known as IGF1A, IGF-1, IGF1, Somatomedin C, Insulin-like growth factor 1, IGF-1 Des(1-3), Des1-3, Des 1-3, Des (1-3), IGF-1 (4-70), IGF DES IGF 1 DES is a polypeptide amino chain that is made up of 67 different amino acids. Studies have shown that this research peptide has high anabolic properties. IGF-1 DES’s tests on animals determined that its functionality is related to hypergenesis, or hyperplasia, noted by an increase in cellular proliferation. IGF DES’s works at the time and location it needs to, for example, needing skin regeneration, cell repair or wound healing. Most impressively, studies also showed a direct correlation between the presence of this peptide and neuroregeneration. This opens a huge window of opportunity for further research into IGF1-DES's ability to increase lean body mass, induce fat loss and increase physical endurance.

IGF1-DES side effects

IGF1-DES has few if any side effects such as redness or itching at site

Also known as Insulin Growth Factor 1 Long R3 IGF-1 LR3 is a single chain of polypeptides which consists of 83 amino acids. The growth factor IGF1 has many other effects which helps promoting growth and development in growth hormone (GH; MIM 139250). There is a long-term analog of IGF-1 human growth factor i-e LR3, which is responsible for support of recombinant biopharmaceuticals manufacture at large.

IGF1-LR3 side effects

IGF1-LR3 has few if any side effects such as redness or itching at site of injection and some increase in joint pain and headaches which should be accounted for during trial. There are no known health risks associated with IGF1-LR3 injections, especially when compared to traditional hormone-based metabolic, strengthening and growth treatments when compared side by side in animal studies.

IGF1-LR3 dosage

The recommended dosage for IGF-1 LR3 is 40–50 mcg daily, intramuscularly per injection